Alzheimer’s Disease Pocket Book


Alzheimer disease (AD) is the most common cause of dementia in the elderly and accounts for 50 to 80% of dementia cases (Alzheimer’s Association, It is a degenerative neurologic disease with progressive cognitive, behavioral and motor impairment manifested as increased deficits regarding attention, executive function, language, memory, and visuo-spatial skills, and in the ability to function in the home, social and work settings.
Alzheimer’s disease is predominantly observed in people over the age of 65 years (late-onset Alzheimer’s disease), and tends to be more prevalent in women (2 out of 3 cases) than men. Currently there are estimates of up to 5.4 million people in the US that may have Alzheimer’s. This equates to approximately 1 in 8 Americans over 65 years old, and 50%
of over 85 year-olds. In 2006, the worldwide prevalence of Alzheimer’s disease was 26.6 million. By 2050, the prevalence of Alzheimer’s is expected to have quadrupled, to an anticipated 1 in 85 persons worldwide (Brookmeyer et al, 2007).

Drug Class & Related Drugs
Alpha E vitamin e class: vitamins
Amino-Opti-E vitamin e class: vitamins
Aqua Gem-E vitamin e class: vitamins
Aqua-E vitamin e class: vitamins
Aquasol E vitamin e class: vitamins
Aquavite-E vitamin e class: vitamins
Aricept donepezil class: cholinesterase inhibitors
Aricept ODT donepezil class: cholinesterase inhibitors
Axona caprylidene class:
Cognex tacrine class: cholinesterase inhibitors
E Pherol vitamin e class: vitamins
E-Gems vitamin e class: vitamins
Exelon rivastigmine class: cholinesterase inhibitors
Hydergine ergoloid mesylates class: miscellaneous central nervous system agents
Namenda memantine class: miscellaneous central nervous system agents
Namenda XR memantine class: miscellaneous central nervous system agents
Nutr-E-Sol vitamin e class: vitamins
Razadyne galantamine class: cholinesterase inhibitors
Razadyne ER galantamine class: cholinesterase inhibitors
Vita-Plus E Natural vitamin e class: vitamins